These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7676265)

  • 1. Preliminary experience with moclobemide for the treatment of depressive disorders in Malaysia.
    Indran SK
    Singapore Med J; 1995 Apr; 36(2):189-90. PubMed ID: 7676265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
    Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social phobia: long-term treatment outcome and prediction of response--a moclobemide study.
    Versiani M; Amrein R; Montgomery SA
    Int Clin Psychopharmacol; 1997 Sep; 12(5):239-54. PubMed ID: 9466158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What happens to patients after the end of a clinical trial? Systematic follow-up observational study of an open moclobemide trial in major depression.
    Linden M; Baier D; Gothe H; Kohnen R
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):35-43. PubMed ID: 9035226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
    Ramasubbu R
    J Psychiatry Neurosci; 1999 Jan; 24(1):45-50. PubMed ID: 9987207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
    Becker T; Struck M; Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Moclobemide in the long-term treatment of depressed patients].
    Carl G; Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():48-50. PubMed ID: 2511580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
    Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L
    J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of atypical depression with moclobemide: a sequential double controlled study.
    Schweitzer I; Tiller J; Maguire K; Davies B
    Int J Clin Pharmacol Res; 1989; 9(2):111-7. PubMed ID: 2654034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment refractory panic disorder--success of a combined treatment with imipramine, moclobemide and behavior therapy].
    Boerner RJ
    Psychiatr Prax; 1995 Jan; 22(1):30-2. PubMed ID: 7892341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The comparative efficacy of Aurorix and amitriptyline in treating depressions].
    Iakovlev VA
    Voen Med Zh; 1997 Apr; 318(4):37-8. PubMed ID: 9221592
    [No Abstract]   [Full Text] [Related]  

  • 12. [Customary antidepressive treatment in Hungary: moclobemid therapy in everyday practice].
    Bartkó G
    Orv Hetil; 1997 Sep; 138(37):2341-5. PubMed ID: 9340582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline].
    Classen W
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():41-3. PubMed ID: 2587675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression in medical illness. Workshop report.
    Paykel E
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):205-7. PubMed ID: 8468445
    [No Abstract]   [Full Text] [Related]  

  • 15. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA; Schweizer E; Rickels K
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Moclobemide in the treatment of depression--an overview].
    Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():37-40. PubMed ID: 2685855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three times daily dosage schedules.
    Gagiano CA; Müller FG; Berk M; Joubert PM; Brown RG; Schall R
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):4S-9S. PubMed ID: 7593729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. UK Moclobemide Study Group.
    Int Clin Psychopharmacol; 1994; 9(2):109-13. PubMed ID: 8056992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of augmentation with moclobemide on symptoms of schizophrenia.
    Silver H; Aharon N; Hausfater N; Jahjah N
    Int Clin Psychopharmacol; 1999 May; 14(3):193-5. PubMed ID: 10435775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three-times-daily dosage schedules.
    Gagiano CA; Hart GA; Bodemer W; Schall R
    Clin Neuropharmacol; 1994; 17 Suppl 1():S1-8. PubMed ID: 7954480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.